Late-onset ornithine transcarbamylase deficiency mimicking a focal opercular syndrome

Pract Neurol. 2022 Jun;22(3):224-227. doi: 10.1136/practneurol-2021-003196. Epub 2022 Jan 19.

Abstract

A previously healthy 27-year-old man was brought to hospital after been found late at night confused, agitated and talking incoherently. He represented 12 days later with focal seizures, progressing to anarthria and encephalopathy. MR scan of brain showed diffuse cerebral oedema and his plasma ammonia was >2000 µmol/L (12-55 µmol/L). He developed refractory status epilepticus and subsequently died. Genetic analysis identified an ornithine transcarbamylase (OTC) gene mutation on the X chromosome. We discuss this atypical presentation of OTC deficiency as a rare but treatable cause of hyperammonaemic encephalopathy.

Keywords: clinical neurology; metabolic disease.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Brain Diseases*
  • Genetic Testing
  • Humans
  • Male
  • Ornithine Carbamoyltransferase Deficiency Disease* / complications
  • Ornithine Carbamoyltransferase Deficiency Disease* / diagnosis
  • Ornithine Carbamoyltransferase Deficiency Disease* / genetics
  • Seizures
  • Status Epilepticus*